Although neither of these mechanisms of inhibiting MIF have yet been translated to clinical trials in melanoma, a phase 1 clinical study of an anti-MIF mAb in solid tumors has recently been completed, with results awaited (NCT01765790, Table 2). The gene discussed is MIF; the disease is melanoma.